For patients suffering from keratoconus, collagen crosslinking could be an option of treatment. The cornea is the clear window of the front of the eye and it consists of hundreds of collagen layers that are cross-linked to each other. If the cross-links between layers are lost due to keratoconus, a progressive corneal thinning and stretching will occur. Normal pressure within the eye causes the cornea to bulge forward. When light enters the eye, it passes through the cornea but if the cornea has turned conical, there is a distortion of image. A new nonsurgical, noninvasive treatment, based on collagen cross-linking with Ultraviolet A (UVA, 365nm) and riboflavin (Vitamin B 2), a photosensitizing agent is now available. It has shown to improve corneal strength and to arrest the progression of keratoconus. Talk to Dr. Gailitis at Ophthalmology Consultants today to see if this treatment is right for you.